Research and therapeutics—traditional and emerging therapies in systemic lupus erythematosus
Author:
Affiliation:
1. Rheumatic Diseases Division, Department of Internal Medicine, University of Texas Southwestern Medical Center
2. Dallas VA Medical Center, Dallas, TX, USA
Funder
National Institutes of Health
Alliance for Lupus Research (ALR) and National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Pharmacology (medical),Rheumatology
Link
http://academic.oup.com/rheumatology/article-pdf/56/suppl_1/i100/24245899/kew417.pdf
Reference154 articles.
1. The evolution of drug discovery in systemic lupus erythematosus;Wallace;Nature reviews. Rheumatology,2015
2. Glucocorticoid use and abuse in SLE;Ruiz-Irastorza;Rheumatology (Oxford, England),2012
3. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis;Singh;BMC medicine,2016
4. Long-term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone only;Steinberg;Arthritis and rheumatism,1991
5. The mechanism of action of cyclophosphamide on the nephritis of (NZB x NZW)F1 hybrid mice;Hurd;Clinical and experimental immunology,1977
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus;Acta Pharmaceutica Sinica B;2024-09
2. Beneficial effects of rapamycin on endothelial function in systemic lupus erythematosus;Frontiers in Physiology;2024-08-21
3. KLHDC7B as a Potential Therapeutic Target in Systemic Lupus Erythematosus: Insights from Bulk and Single-Cell RNA-Seq and Spatial Transcriptomics of Epidermal Keratinocytes;2024-08-02
4. Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial;The Lancet Rheumatology;2024-03
5. Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial;Clinical Pharmacology & Therapeutics;2024-02-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3